Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Sep;50(9):711–715. doi: 10.1136/jcp.50.9.711

The dysplastic naevus.

W J Mooi 1
PMCID: PMC500166  PMID: 9389970

Full text

PDF
711

Images in this article

712Image
on p.712
712Image
on p.712
713Image
on p.713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel. J Clin Pathol. 1997 Mar;50(3):202–205. doi: 10.1136/jcp.50.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ackerman A. B., Mihara I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol. 1985 Jan;16(1):87–91. [PubMed] [Google Scholar]
  3. Ackerman A. B. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology. 1988 Sep;13(3):241–256. doi: 10.1111/j.1365-2559.1988.tb02036.x. [DOI] [PubMed] [Google Scholar]
  4. Armstrong B. K., Heenan P. J., Caruso V., Glancy R. J., Holman C. D. Seasonal variation in the junctional component of pigmented naevi. Int J Cancer. 1984 Oct 15;34(4):441–442. doi: 10.1002/ijc.2910340402. [DOI] [PubMed] [Google Scholar]
  5. Barnes L. M., Nordlund J. J. The natural history of dysplastic nevi. A case history illustrating their evolution. Arch Dermatol. 1987 Aug;123(8):1059–1061. [PubMed] [Google Scholar]
  6. Barnhill R. L., Roush G. C., Duray P. H. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol. 1990 Jan;21(1):51–58. doi: 10.1016/0046-8177(90)90075-g. [DOI] [PubMed] [Google Scholar]
  7. Bergman W., Gruis N. A., Sandkuijl L. A., Frants R. R. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9. J Invest Dermatol. 1994 Nov;103(5 Suppl):122S–125S. doi: 10.1111/1523-1747.ep12399430. [DOI] [PubMed] [Google Scholar]
  8. Black W. C., Hunt W. C. Histologic correlations with the clinical diagnosis of dysplastic nevus. Am J Surg Pathol. 1990 Jan;14(1):44–52. doi: 10.1097/00000478-199001000-00005. [DOI] [PubMed] [Google Scholar]
  9. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24):1893–1904. doi: 10.1093/jnci/81.24.1893. [DOI] [PubMed] [Google Scholar]
  10. Clark W. H., Jr, Reimer R. R., Greene M., Ainsworth A. M., Mastrangelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol. 1978 May;114(5):732–738. [PubMed] [Google Scholar]
  11. Cook M. G., Clarke T. J., Humphreys S., Fletcher A., McLaren K. M., Smith N. P., Stevens A., Theaker J. M., Melia J. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology. 1996 Jun;28(6):497–512. doi: 10.1046/j.1365-2559.1996.d01-464.x. [DOI] [PubMed] [Google Scholar]
  12. Cook M. G., Fallowfield M. E. Dysplastic naevi--an alternative view. Histopathology. 1990 Jan;16(1):29–35. doi: 10.1111/j.1365-2559.1990.tb01056.x. [DOI] [PubMed] [Google Scholar]
  13. Cooke K. R., Spears G. F., Elder D. E., Greene M. H. Dysplastic naevi in a population-based survey. Cancer. 1989 Mar 15;63(6):1240–1244. doi: 10.1002/1097-0142(19890315)63:6<1240::aid-cncr2820630635>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  14. Duncan L. M., Berwick M., Bruijn J. A., Byers H. R., Mihm M. C., Barnhill R. L. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol. 1993 Mar;100(3):318S–321S. doi: 10.1111/1523-1747.ep12470215. [DOI] [PubMed] [Google Scholar]
  15. Duray P. H., DerSimonian R., Barnhill R., Stenn K., Ernstoff M. S., Fine J., Kirkwood J. M. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol. 1992 Nov;27(5 Pt 1):741–749. doi: 10.1016/0190-9622(92)70248-e. [DOI] [PubMed] [Google Scholar]
  16. Elder D. E., Goldman L. I., Goldman S. C., Greene M. H., Clark W. H., Jr Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980 Oct 15;46(8):1787–1794. doi: 10.1002/1097-0142(19801015)46:8<1787::aid-cncr2820460816>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  17. Frichot B. C., 3rd, Lynch H. T., Guirgis H. A., Harris R. E., Lynch J. F. New cutaneous phenotype in familial malignant melanoma. Lancet. 1977 Apr 16;1(8016):864–865. doi: 10.1016/s0140-6736(77)92822-7. [DOI] [PubMed] [Google Scholar]
  18. Halpern A. C., Guerry D., 4th, Elder D. E., Trock B., Synnestvedt M., Humphreys T. Natural history of dysplastic nevi. J Am Acad Dermatol. 1993 Jul;29(1):51–57. doi: 10.1016/0190-9622(93)70151-i. [DOI] [PubMed] [Google Scholar]
  19. Hartge P., Holly E. A., Halpern A., Sagebiel R., Guerry D., Elder D., Clark W., Hanson L., Harrison C., Tarone R. Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):37–40. [PubMed] [Google Scholar]
  20. Hastrup N., Hou-Jensen K. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi. APMIS. 1993 Nov;101(11):845–850. doi: 10.1111/j.1699-0463.1993.tb00190.x. [DOI] [PubMed] [Google Scholar]
  21. Lynch H. T., Frichot B. C., 3rd, Lynch J. F. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978 Oct;15(5):352–356. doi: 10.1136/jmg.15.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meyer L. J., Piepkorn M., Goldgar D. E., Lewis C. M., Cannon-Albright L. A., Zone J. J., Skolnick M. H. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. J Am Acad Dermatol. 1996 Apr;34(4):618–625. doi: 10.1016/s0190-9622(96)80061-2. [DOI] [PubMed] [Google Scholar]
  23. Piepkorn M. W., Barnhill R. L., Cannon-Albright L. A., Elder D. E., Goldgar D. E., Lewis C. M., Maize J. C., Meyer L. J., Rabkin M. S., Sagebiel R. W. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol. 1994 May;30(5 Pt 1):707–714. doi: 10.1016/s0190-9622(08)81499-5. [DOI] [PubMed] [Google Scholar]
  24. Steijlen P. M., Bergman W., Hermans J., Scheffer E., Van Vloten W. A., Ruiter D. J. The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopathology. 1988 Mar;12(3):289–300. doi: 10.1111/j.1365-2559.1988.tb01943.x. [DOI] [PubMed] [Google Scholar]
  25. Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med. 1966 May 26;274(21):1171–1173. doi: 10.1056/NEJM196605262742104. [DOI] [PubMed] [Google Scholar]
  26. de Wit P. E., van't Hof-Grootenboer B., Ruiter D. J., Bondi R., Bröcker E. B., Cesarini J. P., Hastrup N., Hou-Jensen K., MacKie R. M., Scheffer E. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer. 1993;29A(6):831–839. doi: 10.1016/s0959-8049(05)80419-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES